Fred Alger Management, LLC Mereo Biopharma Group PLC Transaction History
Fred Alger Management, LLC
- $20.1 Billion
- Q2 2024
A detailed history of Fred Alger Management, LLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Fred Alger Management, LLC holds 49,304 shares of MREO stock, worth $204,118. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,304
Previous 194,879
74.7%
Holding current value
$204,118
Previous $643,000
72.47%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MREO
# of Institutions
85Shares Held
102MCall Options Held
121KPut Options Held
208K-
Rubric Capital Management LP New York, NY15.3MShares$63.4 Million1.63% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.8MShares$48.8 Million0.08% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.28MShares$38.4 Million1.04% of portfolio
-
Mangrove Partners New York, NY8.75MShares$36.2 Million3.54% of portfolio
-
Janus Henderson Group PLC London, X07.88MShares$32.6 Million0.02% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $517M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...